OakChart

Acadia Healthcare Company Inc

ACHCHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 12 • 3:59 PM ET

37.81-0.99 (-2.55%)
2026-11-13 13:01 CET
Market cap
$3.52B
Revenue, TTM
3,411.41 USD m
Net income, TTM
-1,128.00 USD m
Free cash flow, TTM
-23.86 USD m
EPS diluted, TTM
-12.48
Price / earnings
-
Compare

Price

ACHC against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 39Sales 861Price85585620.0025.0030.0035.0040.007.8M15.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ACHCclose 37.8120-day 32.6950-day 30.24200-day 26.7537.8152w high 39.7052-week range, not 6 months

4.8% under the 52-week high of 39.70 on 9 Nov 2026. 52-week low 11.43 on 15 Jan 2026. Last 15 sessions, 37.4% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 39
CANSLIM 4 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%)
VCP 5 of 6 — fails: RSI (14): Not Overbought (<60)
Minervini 4 of 4
Zanger 3 of 5 — fails: Performance: Week +10%; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 4 of 4
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 3 of 3

Profile

ACHC
52-week range, 93% of the way up
11.4339.70

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.

IndexRUT
Employees25000
IPONov 01, 2011
Beta0.61
ATR, 14d1.90
Rel volume0.00
Short float21.80%
Insider own6.49%
Inst own138.66%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$3.52B
Enterprise Value6.09B
Income-1.13B
Sales3.41B
Book / share22.25
Cash / share1.76
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees25000
IPONov 01, 2011

Ratios

Price / earnings-
Forward price / earnings18.55
Price / earnings / growth2.74
Price / sales1.03
Price / book1.70
Price / cash21.52
Price / free cash flow-
Value / cash profit11.38
Value / sales1.78
Quick Ratio1.59
Current Ratio1.60
Debt / equity1.24
Long-term debt / equity1.21
Options and shortYes / Yes

Earnings

Earnings / share-12.48
Earnings next year2.04
Earnings next quarter0.39
Earnings this year-12.91%
Earnings next year17.02%
Earnings growth, 5 years6.76%
Past earnings growth- -
Past sales growth8.27% 9.65%
Earnings vs last year-1156.09%
Sales vs last year4.47%
Earnings vs last quarter-6.05%
Sales vs last quarter5.14%
EarningsNov 04 AMC
Surprise29.73% 2.00%

Ownership

Insiders own6.49%
Insider trades0.00%
Institutions own138.66%
Institution trades-2.17%
Return on assets-18.85%
Return on equity-43.87%
Return on capital-25.22%
Gross Margin16.10%
Operating margin9.77%
Profit Margin-33.07%
20-day average15.68%
50-day average25.04%
200-day average41.32%

Technical

Shares out90.91M
Shares floating86.93M
Short / float21.80%
Short ratio10.56
Short interest18.95M
52-week high39.70 -4.8%
52-week low11.43 +230.8%
Volatility5.26% 5.38%
Average range1.90
Strength index72.86
Market sensitivity0.61
Relative volume0.00
Avg Volume1.80M
Volume0

Performance

Perf Week8.68%
Perf Month19.39%
Perf Quarter22.64%
Perf Half Y41.08%
Perf YTD166.46%
Perf Year117.17%
Perf 3Y-48.28%
Perf 5Y-41.59%
Perf 10Y-2.50%
Recommendation2.00
Target Price39.07
Prev Close37.81
Price37.81
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 28, 2026DowngradeRaymond JamesStrong Buy → Outperform$39+3.1%
Jun 03, 2026UpgradeJefferiesHold → Buy$30-20.7%
May 04, 2026UpgradeRaymond JamesOutperform → Strong Buy$39+3.1%
Jan 22, 2026DowngradeJefferiesBuy → Hold$15-60.3%
Dec 03, 2025DowngradeLeerink PartnersOutperform → Market Perform$14-63.0%
Dec 03, 2025DowngradeBofA SecuritiesNeutral → Underperform$13-65.6%
Sep 10, 2025DowngradeBofA SecuritiesBuy → Neutral$25-33.9%
Aug 14, 2025DowngradeRaymond JamesStrong Buy → Outperform$26-31.2%
Feb 28, 2025DowngradeBarclaysOverweight → Equal Weight$43 → $35-7.4%
Jan 07, 2025UpgradeKeyBanc Capital MarketsSector Weight → Overweight$70+85.1%

Peers

Mkt cap
TickerCompanyMkt cap
UHSUniversal Health Services Inc11.15B
LFSTLifeStance Health Group Inc5.38B
EHCEncompass Health Corp13.82B
THCTenet Healthcare Corp22.92B
CYHCommunity Health Systems Inc311.67M
ARDTArdent Health Inc2.49B
HCAHCA Healthcare Inc106.27B
NUTXNutex Health Inc1.18B
TDOCTeladoc Health Inc1.60B
BTSGBrightSpring Health Services Inc14.22B

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 107.13B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
AVUVAvantis U.S. Small Cap Value ETFAUM: 33.08B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.56B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.54B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.88B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 9.04B
IWNiShares Russell 2000 Value ETFAUM: 14.17B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 0.600 beat 0.463, from 0.720 a year earlier. Sales 895.31 beat 877.76, from 851.57 a year earlier
EPS
0.83002024Q4 EPS 0.640 against 0.71524Q42025Q1 EPS 0.400 against 0.35725Q12025Q2 EPS 0.830 against 0.69525Q22025Q3 EPS 0.720 against 0.66025Q32025Q4 EPS 0.070 against 0.00925Q42026Q1 EPS 0.370 against 0.26526Q12026Q2 EPS 0.380 against 0.34626Q22026Q3 EPS 0.600 against 0.46326Q3
Sales, USD millions
895.3102024Q4 sales 774.24 against 778.9824Q42025Q1 sales 770.51 against 769.925Q12025Q2 sales 869.23 against 839.325Q22025Q3 sales 851.57 against 846.3625Q32025Q4 sales 821.46 against 800.225Q42026Q1 sales 828.8 against 823.5126Q12026Q2 sales 865.84 against 844.1926Q22026Q3 sales 895.31 against 877.7626Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-04 16:300.6000.4630.380895.31877.76EPS +29.7% · sales +2.0%vs 2025Q3, year-ago quarter · EPS -16.7% · sales +5.1%13 EPS · 12 salesOpen +15.29% vs SPY -0.17%. Close +7.88% vs SPY -4.41%
2026Q2ended 2026-06-302026-07-28 16:300.3800.3460.120865.84844.19EPS +9.7% · sales +2.6%vs 2025Q2, year-ago quarter · EPS -54.2% · sales -0.4%11 EPS · 10 salesOpen +0.70% vs SPY -0.12%. Close -16.34% vs SPY -1.54%
2026Q1ended 2026-03-312026-04-29 16:300.3700.2650.045828.8823.51EPS +39.7% · sales +0.6%vs 2025Q1, year-ago quarter · EPS -7.5% · sales +7.6%13 EPS · 12 salesOpen -4.00% vs SPY +0.43%. Close -8.37% vs SPY +0.99%
2025Q4ended 2025-12-312026-02-25 08:300.0700.009-13.020821.46800.2EPS +686.5% · sales +2.7%vs 2024Q4, year-ago quarter · EPS -89.1% · sales +6.1%13 EPS · 11 salesOpen +18.26% vs SPY +0.41%. Close +21.37% vs SPY +0.84%
2025Q3ended 2025-09-302025-11-05 16:300.7200.6600.400851.57846.36EPS +9.1% · sales +0.6%vs 2024Q3, year-ago quarter · EPS -20.9% · sales +4.4%13 EPS · 12 salesOpen -8.12% vs SPY -0.16%. Close -2.03% vs SPY -1.07%
2025Q2ended 2025-06-302025-08-05 16:300.8300.6950.333869.23839.3EPS +19.5% · sales +3.6%vs 2024Q2, year-ago quarter · EPS -8.8% · sales +9.2%13 EPS · 11 salesOpen -4.50% vs SPY +0.17%. Close -17.28% vs SPY +0.77%
2025Q1ended 2025-03-312025-05-12 16:300.4000.3570.091770.51769.9EPS +12.1% · sales +0.1%vs 2024Q1, year-ago quarter · EPS -52.4% · sales +0.3%13 EPS · 12 salesOpen +1.63% vs SPY +0.07%. Close +4.26% vs SPY +0.66%
2024Q4ended 2024-12-312025-02-27 16:300.6400.7150.355774.24778.98EPS -10.4% · sales -0.6%vs 2023Q4, year-ago quarter · EPS -24.7% · sales +4.2%13 EPS · 12 salesOpen -19.27% vs SPY +0.09%. Close -25.53% vs SPY +1.56%
2024Q3ended 2024-09-302024-10-30 16:300.9100.8990.739815.63819.42EPS +1.2% · sales -0.5%vs 2023Q3, year-ago quarter · EPS 0.0% · sales +8.7%13 EPS · 12 salesOpen -12.63% vs SPY -0.77%. Close -18.03% vs SPY -1.96%
2024Q2ended 2024-06-302024-07-31 16:300.9100.8760.853796.04785.73EPS +3.8% · sales +1.3%vs 2023Q2, year-ago quarter · EPS -1.1% · sales +8.8%11Open +6.80% vs SPY +0.32%. Close +14.25% vs SPY -1.42%
2024Q1ended 2024-03-312024-05-01 16:300.8400.7970.830768.05779.17EPS +5.4% · sales -1.4%vs 2023Q1, year-ago quarter · EPS +12.0% · sales +9.1%12 EPS · 11 salesOpen -3.90% vs SPY +0.76%. Close -8.58% vs SPY +0.94%
2023Q4ended 2023-12-312024-02-27 16:300.8500.7930.628742.8727.6EPS +7.2% · sales +2.1%vs 2022Q4, year-ago quarter · EPS +21.4% · sales +10.0%11Open -0.81% vs SPY -0.32%. Close -4.52% vs SPY -0.13%
2023Q3ended 2023-09-302023-11-02 16:300.9100.892-2.388750.33726.23EPS +2.0% · sales +3.3%vs 2022Q3, year-ago quarter · EPS +13.7% · sales +12.5%11 EPS · 10 sales-
2023Q2ended 2023-06-302023-07-27 16:300.9200.8580.790731.34711.92EPS +7.3% · sales +2.7%vs 2022Q2, year-ago quarter · EPS +9.5% · sales +12.2%12-
2023Q1ended 2023-03-312023-04-26 16:300.7500.7100.722704.27689.62EPS +5.7% · sales +2.1%vs 2022Q1, year-ago quarter · EPS +11.9% · sales +14.2%12-
2022Q4ended 2022-12-312023-02-27 16:300.7000.7490.665675.3660.39EPS -6.6% · sales +2.3%vs 2021Q4, year-ago quarter · EPS -13.6% · sales +13.8%12-

Annual earnings

2025FY EPS 2.000 beat 1.950, from 3.300 a year earlier. Sales 3,313 beat 3,291, from 3,154 a year earlier
EPS
3.44002018FY EPS 2.240 against 2.26320182019FY EPS 2.040 against 2.01820192020FY EPS 2.780 against 2.29620202021FY EPS 2.700 against 2.59420212022FY EPS 3.010 against 3.11020222023FY EPS 3.440 against 3.37820232024FY EPS 3.300 against 3.37820242025FY EPS 2.000 against 1.9502025
Sales, USD millions
3,31302018FY sales 3,012 against 3,01420182019FY sales 3,107 against 3,10720192020FY sales 2,902 against 3,19320202021FY sales 2,314 against 2,30920212022FY sales 2,610 against 2,59620222023FY sales 2,929 against 2,91420232024FY sales 3,154 against 3,15920242025FY sales 3,313 against 3,2912025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2029FYestimate-3.060--4,18712.36
2028FYestimate-2.434--3,87715.54
2027FYestimate-2.038--3,66218.55
2026FYestimate-1.742--3,45121.71
2025FY2.0001.950-12.1603,3133,2917.10
2024FY3.3003.3782.7773,1543,15912.02
2023FY3.4403.378-0.2382,9292,91422.61
2022FY3.0103.1102.9832,6102,59627.35
2021FY2.7002.5942.2482,3142,30922.48
2020FY2.7802.2962.2032,9023,19318.08
2019FY2.0402.0181.2403,1073,10716.28
2018FY2.2402.263-2.0143,0123,01411.48
2017FY2.3002.2342.2952,8362,82614.19
2016FY2.4502.4070.0702,8112,82113.51
2015FY2.2302.2151.6461,7941,78816.96
2014FY1.5401.5281.5001,0051,00624.55
2013FY1.0701.0640.850713.41713.4735.34
2012FY0.6600.6490.530407.46407.7257.29
2011FY0.1200.1200.12062.0162.01315.08

Quarterly results

2026Q3 revenue 895.31, from 851.57 a year earlier. Operating margin 12.7%, from 14.0% a year earlier
Revenue, USD millions
895.3102024Q4 revenue 774.2424Q42025Q1 revenue 770.525Q12025Q2 revenue 869.2325Q22025Q3 revenue 851.5725Q32025Q4 revenue 821.4625Q42026Q1 revenue 828.826Q12026Q2 revenue 865.8426Q22026Q3 revenue 895.3126Q3
Operating margin
16.402024Q4 operating margin 13.4%24Q42025Q1 operating margin 10.2%25Q12025Q2 operating margin 16.4%25Q22025Q3 operating margin 14.0%25Q32025Q4 operating margin 5.8%25Q42026Q1 operating margin 10.1%26Q12026Q2 operating margin 10.1%26Q22026Q3 operating margin 12.7%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 1.74 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-091.74+0.1%
2026Q4Eper share2026-11-090.39+0.5%
2026Q4Rper share2026-11-090.39+1.5%
2026FYSUSD millions2026-11-093,4510.0%
2026Q4S-2026-11-09861.050.0%
2026FYRper share2026-11-060.92-4.0%
2026Q3S-2026-10-13877.760.0%
2026Q3Eper share2026-10-120.460.0%
2026Q3Rper share2026-10-120.470.0%
2026Q2Eper share2026-07-150.350.0%
2026Q2Rper share2026-07-150.330.0%
2026Q2S-2026-07-15844.190.0%
2026Q1S-2026-04-27823.51+0.0%
2026Q1Eper share2026-04-150.26+0.5%
2026Q1Rper share2026-02-260.24-5.0%
2025Q4Eper share2026-02-200.01+2.3%
2025Q4S-2026-02-20800.20.0%
2025FYEper share2026-02-161.950.0%
2025FYRper share2026-02-160.560.0%
2025Q4Rper share2026-02-16-0.200.0%
2025FYSUSD millions2026-01-243,2910.0%
2025Q3Eper share2025-10-310.66-1.7%
2025Q3Rper share2025-10-310.65-2.8%
2025Q3S-2025-10-31846.39+0.1%
2025Q2Eper share2025-07-300.690.0%
2025Q2Rper share2025-07-300.650.0%
2025Q2S-2025-07-28839.30.0%
2025Q1Eper share2025-05-080.36+0.1%
2025Q1Rper share2025-05-080.34-2.9%
2025Q1S-2025-05-08769.9+0.0%
2024FYEper share2025-02-263.380.0%
2024Q4Eper share2025-02-260.71-0.1%
2024FYRper share2025-02-263.23+0.0%
2024FYSUSD millions2025-02-263,159+0.0%
2024Q4S-2025-02-25778.98+0.0%
2024Q4Rper share2025-02-070.69-1.2%
2024Q3S-2024-10-21819.42+0.0%
2024Q3Eper share2024-10-150.900.0%
2024Q3Rper share2024-10-150.900.0%
2024Q2Eper share2024-07-280.870.0%
2024Q2S-2024-07-20784.380.0%
2024Q2Rper share2024-07-180.870.0%
2024Q1S-2024-05-01779.170.0%
2024Q1Eper share2024-04-240.800.0%
2024Q1Rper share2024-04-240.800.0%
2023FYEper share2024-02-263.38-0.1%
2023FYRper share2024-02-26-0.05-18.8%
2023FYSUSD millions2024-02-012,914+0.0%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share2.295-2.0141.242.2032.2482.983-0.2382.777-12.158-12.4789-
Sales USD millions2,8363,0122,0082,0902,3142,6102,9293,1543,3133,411-
Shares million shares878788888990919290-91
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.7390.3550.0910.3330.4-13.020.0450.120.376
Sales USD millions816774771869852821829866895
Shares million shares929290909090919191

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue3,411.413,312.77+5.0%3,153.96+7.7%2,928.74+12.2%2,610.40+12.8%2,314.39+10.7%2,089.93+4.1%2,008.38-33.3%3,012.44
Cost of Goods Sold Incl. D&A2,862.142,729.33+11.8%2,441.98+8.7%2,246.13+12.0%2,006.14+12.6%1,781.08+8.8%1,636.65+3.9%1,575.84-33.6%2,372.27
Gross Profit549.27583.44-18.1%711.98+4.3%682.61+13.0%604.26+13.3%533.31+17.7%453.28+4.8%432.55-32.4%640.17
Selling, General and Administrative Excl. Other215.95195.47+3.0%189.71+7.8%176.01+11.4%158.01+15.6%136.74+13.5%120.49+1.7%118.45-47.9%227.43
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income333.32387.96-25.7%522.28+3.1%506.60+13.5%446.24+12.5%396.57+19.2%332.79+6.0%314.09-23.9%412.74
Interest Expense151.71138.86+19.3%116.37+41.7%82.12+17.7%69.76-9.4%76.99-51.3%158.10-15.6%187.32+1.0%185.41
Unusual Expense1,264.961,323.76+1967.4%64.03-86.1%459.58+19540.2%2.34-94.7%43.82-9.12-118.9%48.37-87.8%396.29
Net Income Before Taxes-1,079.96-1,065.94-411.8%341.88-25.36-106.8%374.14+35.7%275.76+50.0%183.80+134.5%78.39-168.95
Income Taxes41.9125.98-66.4%77.39-9.70-110.3%94.11+39.3%67.56+66.4%40.61+61.9%25.09+284.2%6.53
Consolidated Net Income-1,121.87-1,091.92-512.9%264.48-15.66-105.6%280.03+34.5%208.20+45.4%143.19+168.6%53.31-175.49
Net Income From Continuing Operations-1,128.00-1,102.77-531.4%255.61-21.67-107.9%273.14+34.4%203.28+44.9%140.26+169.2%52.11-175.75
Net Income-1,128.00-1,102.77-531.4%255.61-21.67-107.9%273.14+33.8%204.12+4.6%195.19+79.2%108.92-175.75
EPS (Recurring) per share-2.64-1.94-159.5%3.26-1.2%3.30+10.0%3.00+15.8%2.59+21.6%2.13+30.7%1.63+40.5%1.16
EPS (Basic, Before Extraordinaries) per share-12.47-12.16-535.8%2.79-0.24-107.9%3.05+32.6%2.30+3.6%2.22+79.0%1.24-2.01
EPS (Diluted) per share-12.48-12.16-537.4%2.78-0.24-108.1%2.98+32.4%2.25+2.3%2.20+77.4%1.24-2.01
EBITDA535.06577.21-14.1%671.87+5.2%638.95+13.3%564.01+12.1%503.29+17.6%428.04+6.5%402.02-29.7%571.58
Non-Operating Income (Expense)3.398.710.00-100.0%9.750.000.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense27.1423.11-14.4%27.01+5.9%25.51+9.0%23.41-14.6%27.40+66.8%16.43+30.1%12.63-27.3%17.38
Price To Earnings Ratio ratio statement ratio, not the snapshot--13.00-26.5626.7922.8726.79-
Price To Sales Ratio ratio0.740.391.162.412.892.382.131.450.74
Gross Margin %16.1017.6122.5723.3123.1523.0421.6921.5421.25
Operating Margin %9.7711.7116.5617.3017.0917.1415.9215.6413.70
Net Margin %-33.07-33.298.10-0.7410.468.829.345.42-5.83
Shares Outstanding million shares90.9190.45-1.4%91.78+0.6%91.26+1.5%89.91+1.0%89.03+1.1%88.02+0.3%87.72+0.3%87.44
Market Capitalization3,515.073,515.07-4.6%3,682.90-48.6%7,170.76-4.3%7,489.20+37.2%5,459.09+22.1%4,472.70+52.0%2,942.30+29.7%2,269.06

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue895.31+5.1%865.84-0.4%828.80+7.6%821.46+6.1%851.57+4.4%869.23+9.2%770.50+0.3%774.24+4.2%
Cost of Goods Sold Incl. D&A722.58+6.2%722.31+6.7%691.77+7.0%725.49+16.4%680.57+9.8%676.97+11.8%646.30+8.9%623.31+8.9%
Gross Profit172.73+1.0%143.53-25.3%137.03+10.3%95.97-36.4%171.00-12.6%192.26+0.8%124.20-28.9%150.93-11.5%
Selling, General and Administrative Excl. Other58.66+13.9%55.76+11.6%53.20+16.4%48.33+1.8%51.48+6.1%49.96+4.0%45.71+0.0%47.47+4.2%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income114.07-4.6%87.77-38.3%83.84+6.8%47.64-54.0%119.52-18.8%142.30-0.3%78.50-39.1%103.46-17.3%
Interest Expense37.28+1.8%38.18+8.7%38.33+31.4%37.92+26.1%36.62+22.4%35.14+20.5%29.18+7.2%30.07+46.9%
Unusual Expense20.13-53.1%29.94-54.6%35.76-0.2%1,179.12+3232.7%42.92+129.4%65.88+829.2%35.84+1157.5%35.38+3.0%
Net Income Before Taxes56.47+41.2%22.01-56.0%10.96-18.6%-1,169.40-3176.6%39.98-59.4%50.00-53.0%13.47-86.4%38.01-52.5%
Income Taxes17.82+967.1%9.75-19.2%6.50+47.7%7.84+75.0%1.67-93.9%12.07-52.9%4.40-78.1%4.48-77.8%
Consolidated Net Income38.65+0.9%12.26-67.7%4.46-50.8%-1,177.24-3611.0%38.32-46.3%37.94-53.1%9.06-88.5%33.53-43.9%
Net Income From Continuing Operations34.49-4.9%10.93-63.7%4.11-50.9%-1,177.52-3709.8%36.25-46.8%30.13-61.6%8.37-89.0%32.62-43.5%
Net Income34.49-4.9%10.93-63.7%4.11-50.9%-1,177.52-3709.8%36.25-46.8%30.13-61.6%8.37-89.0%32.62-43.5%
EPS (Recurring) per share0.53-27.4%0.35-58.3%0.32-11.1%-3.89-727.4%0.73-17.0%0.84-7.7%0.36-57.6%0.62-30.3%
EPS (Basic, Before Extraordinaries) per share0.38-5.0%0.12-63.6%0.05-44.4%-13.02-3716.7%0.40-45.9%0.33-61.6%0.09-89.3%0.36-42.9%
EPS (Diluted) per share0.38-5.0%0.12-63.6%0.05-44.4%-13.02-3820.0%0.40-45.9%0.33-61.2%0.09-89.2%0.35-44.4%
EBITDA167.20+0.1%138.20-27.8%136.26+8.5%93.40-34.7%166.99-9.7%191.30+7.0%125.53-24.0%143.00-10.9%
Non-Operating Income (Expense)-0.192.36-72.9%1.220.000.008.710.000.00-100.0%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.75+34.2%8.09+5.8%5.86-6.7%6.45-19.2%5.03-32.8%7.65+9.1%6.280.0%7.98+10.4%
Price To Earnings Ratio ratio statement ratio, not the snapshot---12.0416.3111.1410.9213.00
Price To Sales Ratio ratio0.740.800.630.390.690.640.881.16
Gross Margin %19.2916.5816.5311.6820.0822.1216.1219.49
Operating Margin %12.7410.1410.125.8014.0416.3710.1913.36
Net Margin %3.851.260.50-143.344.263.471.094.21
Shares Outstanding million shares90.91+0.5%90.87+0.5%90.76+0.4%90.45-1.4%90.43-1.4%90.39-1.4%90.39-1.3%91.78+0.6%
Market Capitalization3,515.07+53.7%2,715.79+29.9%2,156.83-23.4%1,309.14-64.5%2,286.50-61.2%2,090.25-66.6%2,817.12-61.5%3,682.90-48.6%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments133.24+74.6%76.31-23.7%100.07+2.5%97.65-27.0%133.81-64.7%378.70+280.5%99.53+97.1%50.51-24.9%67.29
Short Term Receivables545.16+29.2%421.98-1.8%429.53+21.4%353.74+16.2%304.45+2.5%297.08-7.5%321.06-8.8%352.06-2.2%360.02
Inventories5.69+0.7%5.65+6.6%5.30+4.1%5.09+6.3%4.79-1.2%4.85+18.9%4.08-19.2%5.05+5.4%4.79
Other Current Assets130.05+76.8%73.56+20.4%61.10+23.1%49.65-4.5%51.98-97.2%1,842.76+1467.8%117.54+174.7%42.79+8.5%39.45
Total Current Assets814.14+41.0%577.49-3.1%596.00+17.8%506.12+2.2%495.03-80.4%2,523.39+365.4%542.21+20.4%450.42-4.5%471.55
Net Property, Plant & Equipment3,245.22+9.2%2,971.56+24.6%2,384.39+14.2%2,087.28+9.6%1,904.92+10.8%1,719.83+7.7%1,597.38-48.6%3,107.77+2.0%3,048.13
Total Investments and Advances0.000.000.000.000.000.000.00-100.0%60.52+295.6%15.30
Long-Term Note Receivable21.60+145.5%8.80-69.3%28.70+4.0%27.60+1.8%27.10+32.8%20.40+270.9%5.50-9.8%6.10+19.6%5.10
Intangible Assets1,393.01-40.3%2,334.85+1.5%2,299.24+0.0%2,298.85+1.3%2,270.08+4.4%2,173.80+0.9%2,153.93-13.3%2,485.40-12.4%2,838.52
Deferred Tax Assets2.53-87.9%20.96+214.7%6.66+125.8%2.95-4.2%3.08-4.0%3.21-3.9%3.34-3.7%3.47-7.0%3.73
Other Assets50.95+17.8%43.24-1.4%43.85-32.6%65.10-4.1%67.86+15.5%58.73-97.7%2,576.78+4280.0%58.83+39.5%42.17
Total Assets5,527.45-7.2%5,956.91+11.2%5,358.84+7.4%4,987.90+4.6%4,768.08-26.6%6,499.36-5.5%6,879.14+11.4%6,172.50-3.9%6,424.50
Short Term Debt Incl. Current Port. of LT Debt50.69-51.0%103.37+83.0%56.48+16.0%48.70+13.4%42.93-79.0%204.58+212.1%65.56+92.2%34.11-2.1%34.83
Accounts Payable150.40-35.4%232.70+49.0%156.13+49.1%104.72+6.2%98.58+12.3%87.81-2.7%90.26-23.3%117.74+15.1%102.30
Income Tax Payable--0.00-100.0%1.34-75.8%5.54-66.1%16.340.00-100.0%3.04+201.0%1.01
Other Current Liabilities324.10+34.0%241.85-64.1%673.17+188.2%233.56-9.4%257.81-74.2%999.44+224.7%307.76+17.7%261.48+9.3%239.25
Total Current Liabilities525.19-9.1%577.92-34.8%885.78+128.1%388.33-4.1%404.86-69.1%1,308.18+182.2%463.58+11.3%416.38+10.3%377.39
Long Term Debt2,604.20+30.7%1,992.73+37.0%1,454.25-2.5%1,491.83-7.1%1,606.27-47.6%3,063.72-5.2%3,230.78+2.3%3,159.38-1.4%3,205.06
Provision for Risks Charges159.70+94.3%82.20-18.5%100.900.000.00-100.0%2.50-19.4%3.10+10.7%2.80+10.2%2.54
Deferred Tax Liabilities66.61-20.7%83.95+4249.7%1.93-97.9%92.59+24.5%74.37+48.7%50.02+119.2%22.82-71.6%80.37+0.0%80.33
Other Liabilities31.19+6.5%29.29+3.4%28.32-75.2%114.17+14.5%99.70-17.0%120.17-80.6%620.33+309.6%151.46-7.6%163.89
Total Liabilities3,386.90+22.4%2,766.08+11.9%2,471.18+18.4%2,086.92-4.5%2,185.20-51.9%4,544.59+4.7%4,340.61+13.9%3,810.39-0.5%3,829.21
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,948.96-36.6%3,073.72+10.5%2,781.97-1.1%2,812.73+11.7%2,517.49+32.5%1,899.46-24.2%2,505.38+7.4%2,333.31-9.3%2,572.87
Total Shareholders Equity1,948.96-36.6%3,073.72+10.5%2,781.97-1.1%2,812.73+11.7%2,517.49+32.5%1,899.46-24.2%2,505.38+7.4%2,333.31-9.3%2,572.87
Accumulated Minority Interest191.59+63.6%117.12+10.8%105.69+19.7%88.26+35.0%65.39+18.2%55.31+66.8%33.15+15.1%28.81+28.5%22.42
Total Equity2,140.55-32.9%3,190.83+10.5%2,887.66-0.5%2,900.98+12.3%2,582.88+32.1%1,954.77-23.0%2,538.53+7.5%2,362.11-9.0%2,595.29
Total Liabilities & Stockholders Equity5,527.45-7.2%5,956.91+11.2%5,358.84+7.4%4,987.90+4.6%4,768.08-26.6%6,499.36-5.5%6,879.14+11.4%6,172.50-3.9%6,424.50
Book Value Per Share per share21.55-35.7%33.49+9.9%30.48-2.6%31.28+10.6%28.28+31.0%21.58-24.4%28.56+7.0%26.68-9.7%29.55
Tangible Book Value Per Share per share6.15-23.6%8.05+52.2%5.29-7.5%5.72+105.8%2.78-3.12-177.8%4.01-1.74-3.05
Full-Time Employees people25,000-2.0%25,500+8.5%23,500+2.2%23,000+2.2%22,500-46.7%42,200-1.4%42,800+1.7%42,100+3.7%40,600
Price to Book Ratio ratio1.701.202.612.702.152.331.160.961.14
Return on Assets %-19.204.52-0.425.603.612.100.80-2.793.21
Return on Equity %-43.918.73-0.7710.259.206.372.15-7.168.43
Return on Invested Capital %-24.225.05-0.516.354.953.931.90-3.203.46
Quick Ratio ratio1.540.990.671.291.211.931.161.071.24
Current Ratio ratio1.551.000.671.301.221.931.171.081.25

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income-1,121.87-1,091.92-512.9%264.48-15.66-105.6%280.03+43.2%195.56-669.20-707.7%110.12-175.49
Depreciation201.74189.25+26.5%149.59+13.0%132.35+12.4%117.77+10.4%106.72+12.0%95.26+8.3%87.92-44.6%158.83
Other Funds (Non Cash)1,054.101,042.14+1837.4%53.79-87.6%433.00+1117.0%35.58-65.8%103.93-89.8%1,016.52+564.0%153.09-62.1%404.06
Funds from Operations158.90140.56-73.8%535.58+17.5%455.71+1.3%449.92+7.6%417.98-15.7%495.68+40.7%352.22-6.7%377.69
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital76.28-8.67-405.88-6221.9%6.63-69.35-43.50-126.7%163.12-19.32-153.1%36.39
Cash from Operating Activities235.19131.90+1.7%129.69-71.9%462.34+21.5%380.57+1.6%374.48-43.2%658.81+97.9%332.90-19.6%414.08
Capital Expenditures-259.05-571.81-690.38-424.13-296.15-244.81-216.62-225.06-341.46
Net Assets From Acquisitions0.00-8.16-53.55-0.35-9.51-139.010.00-44.900.00
Sale of Fixed Assets and Businesses34.6023.85+128.4%10.44-64.5%29.42+316.1%7.07-99.5%1,514.51+1682688.9%0.09-99.2%11.770.00
Purchase or Sale of Investments0.000.000.000.000.00-84.80-8.35-108.6%97.39-18.38
Purchase of Investments0.000.000.000.000.00-84.80-8.35-7.62-18.38
Sale Or Maturity of Investments0.000.000.000.000.000.000.00-100.0%105.010.00
Other Uses-3.38-0.09-2.98-2.16-7.25-31.40-56.97-53.31-1.12
Other Sources0.000.000.000.000.00-100.0%3.140.00-100.0%12.970.00
Cash from Investing Activities-227.84-556.21-736.48-397.22-305.83-130.1%1,017.63-281.84-201.14-360.96
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-4.15-50.030.000.000.000.000.000.000.00
Repurchase of Common Pref Stock-4.15-50.030.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net39.62532.34-8.6%582.15-16.25-113.59-1,648.87-44.37-52.98-61.66
Change in Long Term Debt39.62532.34-8.6%582.15-16.25-113.59-1,648.87-44.37-52.98-61.66
Issuance of Long Term Debt279.002,250.39+244.4%653.48+1533.7%40.000.00-100.0%917.04-8.9%1,006.71+1214.8%76.570.00
Reduction of Long Term Debt-239.38-1,718.04-71.33-56.25-113.59-2,565.90-1,051.08-129.56-61.66
Net Financing Active Other Cash Flow1.79-1.05-220.7%0.87-46.45-1826.8%2.69-65.6%7.81-7.13-8.64-5.67
Other Financing Activities Uses-4.52-9.60-4.31-49.44-12.72-8.49-7.31-8.64-5.67
Cash from Financing Activities37.26481.25-17.5%583.02-62.70-110.90-1,641.06-51.50-61.63-67.33
Exchange Rate Effect---0.000.00-100.0%4.07-0.5%4.09+15.2%3.55-2.57
Net Change in Cash44.6156.94-23.77-1082.2%2.42-36.16-244.88-174.3%329.56+347.3%73.68-16.78
Free Cash Flow-23.86-439.91-560.69-1567.4%38.21-54.7%84.42-34.9%129.67-70.7%442.19+310.0%107.84+48.5%72.62
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio---185.1089.2842.5010.0727.0530.90
Deferred Taxes & Investment Tax Credit-1.09-98.4%67.71-93.98-667.9%16.55+40.6%11.77-77.8%53.11+4772.5%1.09-9.71

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments163.31+37.6%171.29+30.3%158.47+73.7%133.24+74.6%118.69+44.5%131.42+70.3%91.24+18.0%76.31-23.7%
Short Term Receivables561.59+11.7%555.49+15.0%547.73+17.0%545.16+29.2%502.84+2.8%483.23-4.2%468.02-0.6%421.98-1.8%
Inventories6.250.0%6.26+7.6%5.93+3.9%5.69+0.7%6.25+13.4%5.82-2.8%5.71-0.7%5.65+6.6%
Other Current Assets150.18+25.0%112.24+57.9%125.06+69.0%130.05+76.8%120.17+59.7%71.09+23.7%73.98+30.5%73.56+20.4%
Total Current Assets881.32+17.8%845.29+22.2%837.20+31.0%814.14+41.0%747.96+14.7%691.56+7.2%638.95+4.6%577.49-3.1%
Net Property, Plant & Equipment3,187.78-0.6%3,228.72+1.7%3,238.79+5.3%3,245.22+9.2%3,205.75+14.4%3,176.27+21.2%3,076.65+23.2%2,971.56+24.6%
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets1,415.83-40.3%1,403.46-40.4%1,400.00-40.6%1,393.01-40.3%2,371.61+1.4%2,355.70+0.9%2,355.19+0.9%2,334.85+1.5%
Deferred Tax Assets2.42-91.3%2.46-90.3%2.49-89.3%2.53-87.9%27.80+925.8%25.38+826.3%23.18+733.8%20.96+214.7%
Other Assets42.24-29.2%41.40-30.4%67.97+26.8%50.95+17.8%59.63-20.6%59.45-19.9%53.62-25.4%43.24-1.4%
Total Assets5,554.59-13.4%5,546.32-12.1%5,546.45-9.8%5,527.45-7.2%6,412.74+9.2%6,308.36+11.1%6,147.60+11.4%5,956.91+11.2%
Short Term Debt Incl. Current Port. of LT Debt55.33+17.9%54.34+23.5%54.32+28.8%50.69-51.0%46.94-53.0%43.99-53.5%42.16-52.8%103.37+83.0%
Accounts Payable138.56-23.0%135.26-38.5%142.20-30.3%150.40-35.4%179.94-10.6%219.82+37.8%204.01+30.7%232.70+49.0%
Other Current Liabilities358.14+23.1%347.98+33.9%292.83+28.9%324.10+34.0%291.04-5.6%259.89-11.1%227.18-4.1%241.85-64.1%
Total Current Liabilities552.03+6.6%537.58+2.6%489.36+3.4%525.19-9.1%517.92-15.0%523.71-4.2%473.35-1.9%577.92-34.8%
Long Term Debt2,449.41+2.9%2,510.92+7.2%2,615.66+14.4%2,604.20+30.7%2,380.24+24.6%2,341.71+24.6%2,285.61+20.4%1,992.73+37.0%
Provision for Risks Charges0.000.000.00159.70+94.3%0.000.000.0082.20-18.5%
Deferred Tax Liabilities93.64-0.5%87.14+9.5%76.91-4.5%66.61-20.7%94.09+73.9%79.61+115.0%80.54+418.6%83.95+4249.7%
Other Liabilities207.15+58.7%218.84+56.5%196.27+46.3%31.19+6.5%130.56-13.3%139.79-7.2%134.12-8.4%29.29+3.4%
Total Liabilities3,302.22+5.7%3,354.48+8.7%3,378.19+13.6%3,386.90+22.4%3,122.81+14.6%3,084.83+18.0%2,973.62+17.0%2,766.08+11.9%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity2,022.49-35.2%1,979.12-35.7%1,958.28-35.6%1,948.96-36.6%3,120.30+2.9%3,077.99+4.2%3,041.56+6.1%3,073.72+10.5%
Total Shareholders Equity2,022.49-35.2%1,979.12-35.7%1,958.28-35.6%1,948.96-36.6%3,120.30+2.9%3,077.99+4.2%3,041.56+6.1%3,073.72+10.5%
Accumulated Minority Interest229.88+35.5%212.72+46.2%209.98+58.6%191.59+63.6%169.63+48.1%145.54+30.1%132.42+21.1%117.12+10.8%
Total Equity2,252.37-31.5%2,191.85-32.0%2,168.26-31.7%2,140.55-32.9%3,289.93+4.6%3,223.53+5.2%3,173.98+6.7%3,190.83+10.5%
Total Liabilities & Stockholders Equity5,554.59-13.4%5,546.32-12.1%5,546.45-9.8%5,527.45-7.2%6,412.74+9.2%6,308.36+11.1%6,147.60+11.4%5,956.91+11.2%
Book Value Per Share per share22.25-35.5%21.78-36.0%21.58-35.9%21.55-35.7%34.50+4.4%34.05+5.7%33.65+7.5%33.49+9.9%
Tangible Book Value Per Share per share6.67-19.4%6.34-20.7%6.15-19.0%6.15-23.6%8.28+9.5%7.99+18.5%7.59+30.6%8.05+52.2%
Full-Time Employees people---25,000-2.0%---25,500+8.5%
Price to Book Ratio ratio1.701.371.090.410.730.670.911.20
Return on Assets %-18.85-19.00-18.93-19.201.752.323.224.52
Return on Equity %-43.87-44.54-44.28-43.913.494.626.358.73
Return on Invested Capital %0.770.240.09-25.860.660.560.160.64
Quick Ratio ratio1.591.561.701.541.431.311.340.99
Current Ratio ratio1.601.571.711.551.441.321.351.00

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income38.65+0.9%12.26-67.7%4.46-50.8%-1,177.24-3611.0%38.32-46.3%37.94-53.1%9.06-88.5%33.53-43.9%
Depreciation53.13+11.9%50.43+2.9%52.43+11.5%45.75+15.7%47.47+26.1%48.99+35.8%47.03+29.4%39.54+11.8%
Other Funds (Non Cash)14.38+78.9%17.37+212.4%8.39-42.5%1,013.96+6139.8%8.04-61.5%5.56-49.6%14.58+160.4%16.25+427.6%
Funds from Operations112.70+6.4%90.33+1.1%75.62+16.2%-119.74-218.7%105.89-28.0%89.36-40.2%65.05-52.9%100.89+289.7%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-14.8271.74+62.5%-14.0933.45+111.6%-32.68-303.0%44.14+103.6%-53.5815.81-82.5%
Cash from Operating Activities97.88+33.7%162.07+21.4%61.53+436.0%-86.29-173.9%73.21-55.1%133.50-22.0%11.48116.70+0.3%
Capital Expenditures-50.74-38.55-76.56-93.19-136.24-167.75-174.63-203.49
Net Assets From Acquisitions0.000.00-100.0%0.000.000.000.43-8.590.00
Sale of Fixed Assets and Businesses7.40+13.3%10.11-39.0%16.38+40850.0%0.70+233.3%6.53+32550.0%16.58+1341.7%0.04-99.6%0.21-99.3%
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.83-4.24-0.030.06-0.04-0.04-0.06-0.04
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-42.51-32.68-60.21-92.44-129.75-150.78-183.24-203.33
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock-0.34-3.810.000.000.00-3.15-46.880.00
Repurchase of Common Pref Stock-0.34-3.810.000.000.00-3.15-46.880.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-63.12-254.2%-113.12-271.5%25.94-89.0%189.94+138.5%40.94+18.2%65.94235.53-51.3%79.64
Change in Long Term Debt-63.12-254.2%-113.12-271.5%25.94-89.0%189.94+138.5%40.94+18.2%65.94235.53-51.3%79.64
Issuance of Long Term Debt0.00-100.0%0.00-100.0%85.00-95.6%194.00+104.2%45.00-10.0%70.001,941.38+281.8%95.00
Reduction of Long Term Debt-63.12-113.12-59.06-4.06-4.06-4.06-1,705.86-15.36
Net Financing Active Other Cash Flow0.11-96.2%0.36-2.033.34+190.4%2.88+1007.7%-5.32-1.961.15
Other Financing Activities Uses-1.660.12-2.77-0.21-2.12-5.32-1.96-0.53
Cash from Financing Activities-63.36-244.6%-116.57-302.9%23.91-87.2%193.28+139.2%43.82+25.6%57.46186.69-61.4%80.79
Net Change in Cash-7.9812.82-68.1%25.23+69.0%14.55-12.73-355.6%40.1914.93-5.84-1316.7%
Free Cash Flow47.14123.51-15.03-179.48-63.03-34.24-302.5%-163.15-86.79

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Acute Inpatient Psychiatric Facilities1,678.271,830.32+9.1%55.3%
Comprehensive Treatment Centers537.89567.18+5.4%17.1%
Residential Treatment Centers345.79348.07+0.7%10.5%
Specialty Treatment Facilities592.02567.20-4.2%17.1%
Total3,153.963,312.77+5.0%100.0%
Region
Name20242025vs 20242025 share
United States3,153.963,312.77+5.0%100.0%
Total3,153.963,312.77+5.0%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3021.80%19.0M86.9M1.62M
2026-10-1524.05%20.9M87.1M1.91M
2026-09-3026.16%22.8M87.1M2.15M
2026-09-1524.71%21.5M87.1M2.57M
2026-08-3125.94%22.6M87.1M2.77M
2026-08-1424.05%21.0M87.1M2.86M
2026-07-3125.02%21.8M87.1M3.06M
2026-07-1525.34%21.8M86.0M3.09M
2026-06-3026.21%22.5M86.0M3.03M
2026-06-1523.59%20.3M86.0M2.84M
2026-05-2926.70%23.0M86.0M3.00M
2026-05-1526.33%22.6M86.0M3.28M
2026-04-3027.69%23.8M86.1M3.57M
2026-04-1525.80%22.1M85.8M3.73M
2026-03-3125.69%22.1M86.0M3.74M
2026-03-1329.15%25.1M86.0M3.67M
2026-02-2732.02%27.5M86.0M3.75M
2026-02-1337.74%32.5M86.0M3.54M
2026-01-3029.51%26.4M89.3M3.23M
2026-01-1524.59%22.0M89.3M2.85M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call15.0021.6024.900.006.6540.000.000.982-0.0560.002
call17.5019.3022.400.005.8290.000.000.978-0.0550.003
call20.0016.9019.907.405.0211.000.000.974-0.0540.003
call22.5014.6017.400.004.3180.000.000.970-0.0520.004
call25.0012.1014.5013.003.37011.000.000.932-0.1010.007
call30.007.309.308.252.1853270.000.897-0.0890.010
call35.002.853.503.200.80942822.000.801-0.0690.015
call40.000.300.600.470.6281,48592.000.323-0.0950.020
put15.000.001.950.003.4300.000.00-0.018-0.0540.002
put17.500.001.750.002.9090.000.00-0.022-0.0530.003
put20.000.001.750.002.4580.000.00-0.026-0.0520.003
put22.500.000.150.102.0583030.00-0.030-0.0500.004
put25.000.001.750.502.12084.000.00-0.068-0.0980.007
put30.000.000.600.051.35846.000.00-0.103-0.0850.010
put35.000.150.400.400.64947.0035.00-0.199-0.0650.015
put40.001.953.802.201.1375.000.00-0.677-0.0900.020

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-048-KCurrent report2026-11-04SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-08SCHEDULE 13GSEC
2026-09-258-KCurrent report2026-09-25SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-06SCHEDULE 13G/ASEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-27SCHEDULE 13G/ASEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-26SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-05-188-KCurrent report2026-05-18SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-11S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-113Initial statement of beneficial ownership of securities2026-05-01SEC
2026-05-11SCHEDULE 13G/ASEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-084Statement of changes in beneficial ownership of securities2026-05-06SEC
2026-05-064Statement of changes in beneficial ownership of securities2026-05-05SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-304Statement of changes in beneficial ownership of securities2026-04-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.16.26%
WELLINGTON MANAGEMENT GROUP LLP6.23%
VANGUARD PORTFOLIO MANAGEMENT LLC5.84%
CARRONADE CAPITAL MANAGEMENT, LP5.18%
DIMENSIONAL FUND ADVISORS LP5.05%
FMR LLC5.01%
MORGAN STANLEY4.93%
DEERFIELD MANAGEMENT COMPANY, L.P.4.91%
DME Capital Management, LP4.79%
FARALLON CAPITAL MANAGEMENT, L.L.C.4.59%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF6.03%
Virtus Newfleet Multi-Sector Short Term Bond Fund5.19%
Virtus Newfleet Short Duration High Income Fund5.18%
Global Bond Fund4.24%
VOYA STRATEGIC INCOME OPPORTUNITIES FUND3.97%
High Yield Fund3.30%
American Century Diversified Corporate Bond ETF2.64%
Avantis U.S. Small Cap Value ETF2.58%
Guggenheim Strategic Opportunities Fund2.58%
Nomura Strategic Income Fund1.99%

OakChart. ACHC. Cached 15 minutes. Terms

Some panels did not load: insider.